DK1017675T3 - Stærkt lipofile camptothecinderivater - Google Patents
Stærkt lipofile camptothecinderivaterInfo
- Publication number
- DK1017675T3 DK1017675T3 DK98904990T DK98904990T DK1017675T3 DK 1017675 T3 DK1017675 T3 DK 1017675T3 DK 98904990 T DK98904990 T DK 98904990T DK 98904990 T DK98904990 T DK 98904990T DK 1017675 T3 DK1017675 T3 DK 1017675T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- camptothecin derivatives
- strongly lipophilic
- lipophilic camptothecin
- substitution
- Prior art date
Links
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 229940123780 DNA topoisomerase I inhibitor Drugs 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Silicon Polymers (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3714897P | 1997-02-14 | 1997-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1017675T3 true DK1017675T3 (da) | 2006-10-16 |
Family
ID=21892705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98904990T DK1017675T3 (da) | 1997-02-14 | 1998-02-11 | Stærkt lipofile camptothecinderivater |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1017675B1 (da) |
JP (2) | JP4311765B2 (da) |
AT (1) | ATE329903T1 (da) |
AU (1) | AU6272598A (da) |
CA (1) | CA2280905C (da) |
DE (1) | DE69834923T2 (da) |
DK (1) | DK1017675T3 (da) |
ES (1) | ES2262223T3 (da) |
PT (1) | PT1017675E (da) |
WO (1) | WO1998035940A1 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136978A (en) * | 1993-06-30 | 2000-10-24 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
US6150343A (en) | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
US6743917B2 (en) | 1993-06-30 | 2004-06-01 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
FR2790261B1 (fr) * | 1999-02-26 | 2004-09-10 | Sod Conseils Rech Applic | Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation |
EP1017675B1 (en) * | 1997-02-14 | 2006-06-14 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
US6057303A (en) * | 1998-10-20 | 2000-05-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic Camptothecin derivatives |
US6207832B1 (en) * | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
AU4822500A (en) * | 1999-05-04 | 2000-11-17 | Bionumerik Pharmaceuticals, Inc. | Novel highly lipophilic camptothecin analogs |
US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
US6855720B2 (en) | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
US6372906B1 (en) | 2001-04-12 | 2002-04-16 | University Of Pittsburgh | Synthesis of silyl camptothecins and silyl homocamptothecins |
US6723853B2 (en) | 2001-08-27 | 2004-04-20 | University Of Pittsburgh | Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins |
WO2003045952A2 (en) | 2001-11-30 | 2003-06-05 | Chugai Seiyaku Kabushiki Kaisha | Condensed camptothecins as antitumor agents |
US6933302B2 (en) | 2002-06-03 | 2005-08-23 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
EP1393719A1 (en) * | 2002-08-23 | 2004-03-03 | Munich Biotech AG | Camptothecin-carboxylate formulations |
US7067666B2 (en) * | 2003-06-27 | 2006-06-27 | Research Triangle Institute | 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
AU2004305494B2 (en) * | 2003-12-17 | 2009-09-10 | Crown Bioscience, Inc. | Pharmaceutical formulations of camptothecins and process for making same |
WO2005097803A1 (ja) | 2004-04-09 | 2005-10-20 | Chugai Seiyaku Kabushiki Kaisha | 新規水溶性プロドラッグ |
ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
US7875602B2 (en) | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
WO2007075492A1 (en) * | 2005-12-16 | 2007-07-05 | Sonus Pharmaceuticals, Inc. | Lipophilic anticancer drug compounds |
JP2010500350A (ja) * | 2006-08-11 | 2010-01-07 | ザ クリストゥス ステーリン ファウンデーション フォー キャンサー リサーチ | カンプトテシンのエステルの製造法 |
JP5113958B2 (ja) | 2010-06-11 | 2013-01-09 | 独立行政法人科学技術振興機構 | 薬剤多量体微粒子及びその製造方法 |
CN104755482B (zh) * | 2012-10-30 | 2017-04-26 | 内尔维阿诺医学科学有限公司 | 官能化的9‑溴‑喜树碱衍生物 |
FR3029637B1 (fr) | 2014-12-05 | 2018-01-05 | Universite De Strasbourg | Microdispositif de detection de composes organiques volatils et methode de detection d'au moins un compose organique volatil compris dans un echantillon gazeux |
CN111194341B (zh) | 2018-09-14 | 2022-09-23 | 美国陶氏有机硅公司 | 压敏粘合剂及其制备和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
EP1017675B1 (en) * | 1997-02-14 | 2006-06-14 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
-
1998
- 1998-02-11 EP EP98904990A patent/EP1017675B1/en not_active Expired - Lifetime
- 1998-02-11 WO PCT/US1998/002375 patent/WO1998035940A1/en active IP Right Grant
- 1998-02-11 PT PT98904990T patent/PT1017675E/pt unknown
- 1998-02-11 DK DK98904990T patent/DK1017675T3/da active
- 1998-02-11 DE DE69834923T patent/DE69834923T2/de not_active Expired - Lifetime
- 1998-02-11 ES ES98904990T patent/ES2262223T3/es not_active Expired - Lifetime
- 1998-02-11 JP JP53583598A patent/JP4311765B2/ja not_active Expired - Lifetime
- 1998-02-11 AT AT98904990T patent/ATE329903T1/de active
- 1998-02-11 AU AU62725/98A patent/AU6272598A/en not_active Abandoned
- 1998-02-11 CA CA002280905A patent/CA2280905C/en not_active Expired - Lifetime
-
2009
- 2009-03-02 JP JP2009047622A patent/JP5264561B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1998035940A1 (en) | 1998-08-20 |
PT1017675E (pt) | 2006-09-29 |
JP2009149680A (ja) | 2009-07-09 |
AU6272598A (en) | 1998-09-08 |
EP1017675A1 (en) | 2000-07-12 |
DE69834923D1 (en) | 2006-07-27 |
ES2262223T3 (es) | 2006-11-16 |
JP4311765B2 (ja) | 2009-08-12 |
EP1017675A4 (en) | 2001-08-22 |
DE69834923T2 (de) | 2006-10-19 |
JP5264561B2 (ja) | 2013-08-14 |
ATE329903T1 (de) | 2006-07-15 |
JP2001511807A (ja) | 2001-08-14 |
CA2280905A1 (en) | 1998-08-20 |
CA2280905C (en) | 2006-08-29 |
EP1017675B1 (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1017675T3 (da) | Stærkt lipofile camptothecinderivater | |
ATE261974T1 (de) | Hoch-lipophile campothecin-derivate | |
EA200100111A1 (ru) | Ингибиторы фарнезилпротеинтрансферазы, обладающие in vivo радиосенсибилизирующими свойствами | |
TR200000576T1 (tr) | Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem | |
AR022860A1 (es) | Derivados de camptotecina que poseen actividad antitumoral | |
CY1105803T1 (el) | Συνθεση πepιλαμβανουσα καμπτοθεκινη και ενα παραγωγο πυριμιδινης για τη θepαπεια καρκινου | |
PT1212312E (pt) | Novos derivados de flavonas xantonas e cumarinas | |
BG108072A (en) | The use of epothilone derivatives for the treatment of refractory tumors | |
MX9307011A (es) | Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
NO20031410D0 (no) | Antitumorterapi innbefattende distamycinderivater | |
DE69901506D1 (de) | Verwendung von natriumchlorid zur verminderung der gastrointestinalen toxizität von camptotecinderivaten. | |
HUP0302629A2 (hu) | Camptotechin és sztilbénszármazékok kombinációját tartalmazó gyógyszerkészítmények rák kezelésére | |
SE9803107D0 (sv) | Novel Compunds | |
UA38352A (uk) | Засіб для лікувальних ванн |